BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
SIRT1
,
nitric oxide metabolic process
,
Arthritis
,
Lung
,
Nosology
,
Bleomycin
,
rs4950928
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
cancer unknown origin
(phenotype)
Summary
General Info
Genetic Markers
Most Correlated Genes
Most Correlated SNPs
No genes found
No SNPs found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Mouse genetic models of neurofibromatosis tumors
Antioxidant response element activation by DPP3 or SQSTM1 in IMR-32 neuroblastoma cells
Pilocytic astrocytomas from multiple CNS origins and with different MAPK mutations
Craniopharyngiomas, choroid plexus papillomas and medulloblastomas from pediatric patients
OMIM - Neoplasm of brain
Explore Curated Studies Results
Literature
Most Relevant Literature
A Rare Case of Pembrolizumab-Induced Dermatomyositis in a Patient with Cancer of Unknown Primary Ori…
Feasibility of prognosis assessment for cancer of unknown primary origin using texture analysis of 1…
NMDA receptor encephalitis with cancer of unknown primary origin.
Cancer of unknown primary origin; Know the enemy.
Axillary nodal metastases from carcinoma of unknown primary (CUPAx): a systematic review of publish…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Clinical Safety and Efficacy Study of Mebendazole on GI Cancer or Cancer of Unknown Origin.
Antineoplaston Therapy in Treating Patients With Cancer of Unknown Primary Origin
Chemotherapy in Treating Patients With Cancer of Unknown Primary Origin
Gemcitabine, Docetaxel, and Capecitabine in Treating Patients With Cancer of Unknown Primary Origin
Combination Chemotherapy in Treating Patients With Metastatic Cancer of an Unknown Site of Origin
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ